BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8144509)

  • 1. The shape of high molecular weight kininogen. Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy.
    Weisel JW; Nagaswami C; Woodhead JL; DeLa Cadena RA; Page JD; Colman RW
    J Biol Chem; 1994 Apr; 269(13):10100-6. PubMed ID: 8144509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of the high molecular weight kininogen binding site of prekallikrein. Evidence for a discontinuous epitope formed by distinct segments of the prekallikrein heavy chain.
    Herwald H; Jahnen-Dechent W; Alla SA; Hock J; Bouma BN; Müller-Esterl W
    J Biol Chem; 1993 Jul; 268(19):14527-35. PubMed ID: 7686159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain.
    Page JD; You JL; Harris RB; Colman RW
    Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain.
    Thompson RE; Mandle R; Kaplan AP
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4862-6. PubMed ID: 291905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High molecular weight kininogen-binding site of prekallikrein probed by monoclonal antibodies.
    Hock J; Vogel R; Linke RP; Müller-Esterl W
    J Biol Chem; 1990 Jul; 265(20):12005-11. PubMed ID: 1694851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of the discontinuous kininogen binding site of prekallikrein. A distal binding segment is located in the heavy chain domain A4.
    Herwald H; Renné T; Meijers JC; Chung DW; Page JD; Colman RW; Müller-Esterl W
    J Biol Chem; 1996 May; 271(22):13061-7. PubMed ID: 8662705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of the prekallikrein-binding site of human H-kininogen by ligand screening of lambda gt11 expression libraries. Mimicking of the predicted binding site by anti-idiotypic antibodies.
    Vogel R; Kaufmann J; Chung DW; Kellermann J; Müller-Esterl W
    J Biol Chem; 1990 Jul; 265(21):12494-502. PubMed ID: 1695630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
    Wiggins RC; Bouma BN; Cochrane CG; Griffin JH
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4636-40. PubMed ID: 270705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational analysis of synthetic peptides encompassing the factor XI and prekallikrein overlapping binding domains of high molecular weight kininogen.
    You JL; Page JD; Scarsdale JN; Colman RW; Harris RB
    Peptides; 1993; 14(5):867-76. PubMed ID: 8284263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parallel mechanisms of high molecular weight kininogen action as a cofactor in kallikrein inactivation and prekallikrein activation reactions.
    Olson ST; Francis AM; Sheffer R; Choay J
    Biochemistry; 1993 Nov; 32(45):12148-59. PubMed ID: 8218292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calorimetric and spectroscopic examination of the solution phase structures of prekallikrein binding domain peptides of high molecular weight kininogen.
    You JL; Scarsdale JN; Harris RB
    J Protein Chem; 1991 Jun; 10(3):301-11. PubMed ID: 1910462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution phase conformation studies of the prekallikrein binding domain of high molecular weight kininogen.
    Scarsdale JN; Harris RB
    J Protein Chem; 1990 Oct; 9(5):647-59. PubMed ID: 2085389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains.
    Bock PE; Shore JD; Tans G; Griffin JH
    J Biol Chem; 1985 Oct; 260(23):12434-43. PubMed ID: 3850090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371).
    Page JD; Colman RW
    J Biol Chem; 1991 May; 266(13):8143-8. PubMed ID: 1708772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of the discontinuous H-kininogen binding site of plasma prekallikrein. Evidence for a critical role of apple domain-2.
    Renné T; Dedio J; Meijers JC; Chung D; Müller-Esterl W
    J Biol Chem; 1999 Sep; 274(36):25777-84. PubMed ID: 10464316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whale high-molecular-weight and low-molecular-weight kininogens.
    Semba U; Shibuya Y; Okabe H; Hayashi I; Yamamoto T
    Thromb Res; 2000 Mar; 97(6):481-90. PubMed ID: 10704658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma kallikrein structure reveals apple domain disc rotated conformation compared to factor XI.
    Li C; Voos KM; Pathak M; Hall G; McCrae KR; Dreveny I; Li R; Emsley J
    J Thromb Haemost; 2019 May; 17(5):759-770. PubMed ID: 30801944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of factor XI and prekallikrein bound to domain 6 of high-molecular weight kininogen reveal alternate domain 6 conformations and exosites.
    Li C; Barroeta AB; Wong SS; Kim HJ; Pathak M; Dreveny I; Meijers JCM; Emsley J
    J Thromb Haemost; 2023 Sep; 21(9):2378-2389. PubMed ID: 37068593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of the H-kininogen binding site exposed by the prekallikrein heavy chain.
    Herwald H; Hock H; Jahnen-Dechent W; Müller-Esterl W
    Agents Actions Suppl; 1992; 38 ( Pt 1)():225-32. PubMed ID: 1466274
    [No Abstract]   [Full Text] [Related]  

  • 20. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.